JP2009500620A5 - - Google Patents

Info

Publication number

JP2009500620A5

JP2009500620A5 JP2008520024A JP2008520024A JP2009500620A5 JP 2009500620 A5 JP2009500620 A5 JP 2009500620A5 JP 2008520024 A JP2008520024 A JP 2008520024A JP 2008520024 A JP2008520024 A JP 2008520024A JP 2009500620 A5 JP2009500620 A5 JP 2009500620A5

Authority

JP

Japan

Prior art keywords

antigen

aspergillus

dppv

rnu

serum

Prior art date

2006-06-30

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 239000000427 antigen Substances 0.000 claims 43
• 102000036639 antigens Human genes 0.000 claims 43
• 108091007433 antigens Proteins 0.000 claims 43
• 238000000034 method Methods 0.000 claims 25
• 241000228212 Aspergillus Species 0.000 claims 23
• 102000016938 Catalase Human genes 0.000 claims 9
• 108010053835 Catalase Proteins 0.000 claims 9
• 101710087092 Dipeptidyl-peptidase 5 Proteins 0.000 claims 9
• 101710168595 Probable dipeptidyl-peptidase 5 Proteins 0.000 claims 9
• 102000006382 Ribonucleases Human genes 0.000 claims 9
• 108010083644 Ribonucleases Proteins 0.000 claims 9
• 238000009007 Diagnostic Kit Methods 0.000 claims 8
• 238000002965 ELISA Methods 0.000 claims 8
• 210000002966 serum Anatomy 0.000 claims 8
• 201000002909 Aspergillosis Diseases 0.000 claims 6
• 208000036641 Aspergillus infections Diseases 0.000 claims 6
• 239000007787 solid Substances 0.000 claims 5
• OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 claims 4
• 102000004190 Enzymes Human genes 0.000 claims 4
• 108090000790 Enzymes Proteins 0.000 claims 4
• 229920000926 Galactomannan Polymers 0.000 claims 4
• 206010006474 Bronchopulmonary aspergillosis allergic Diseases 0.000 claims 3
• 208000006778 allergic bronchopulmonary aspergillosis Diseases 0.000 claims 3
• 239000002299 complementary DNA Substances 0.000 claims 3
• 201000003883 Cystic fibrosis Diseases 0.000 claims 2
• 238000002835 absorbance Methods 0.000 claims 2
• 230000003321 amplification Effects 0.000 claims 2
• 238000001514 detection method Methods 0.000 claims 2
• 239000003550 marker Substances 0.000 claims 2
• 238000003199 nucleic acid amplification method Methods 0.000 claims 2
• 239000000243 solution Substances 0.000 claims 2
• 239000000758 substrate Substances 0.000 claims 2
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
• 206010003487 Aspergilloma Diseases 0.000 claims 1
• 241001225321 Aspergillus fumigatus Species 0.000 claims 1
• 206010062016 Immunosuppression Diseases 0.000 claims 1
• 229940091771 aspergillus fumigatus Drugs 0.000 claims 1
• 230000015572 biosynthetic process Effects 0.000 claims 1
• 238000010367 cloning Methods 0.000 claims 1
• 230000007812 deficiency Effects 0.000 claims 1
• 239000013604 expression vector Substances 0.000 claims 1
• 230000001506 immunosuppresive effect Effects 0.000 claims 1
• 201000009085 invasive aspergillosis Diseases 0.000 claims 1
• 238000000746 purification Methods 0.000 claims 1
• 238000002054 transplantation Methods 0.000 claims 1
• 239000011534 wash buffer Substances 0.000 claims 1